480 Biomedical's self-expanding scaffold technology platform employs a unique composite design that strikes an optimal balance of strength, flexibility and bioresorption.
Our lead product is the proprietary Stanza™ bioresorbable, drug eluting, scaffold and delivery system for use in treating peripheral artery disease in the superficial femoral artery, a condition that is poorly addressed today.
June 18, 2015
June 1, 2015
480 Biomedical Awarded $1 Million Phase II NHLBI Contract to Advance Bioresorbable Scaffold for Pediatric Pulmonary Artery Stenosis
July 9, 2014
BSI Certificate Awarded
December 11, 2013